Bank of Montreal
PTCT icon

Bank of Montreal’s PTC Therapeutics PTCT Stock Holding History

Bank of Montreal’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,000
Closed -$1.09M – 3862
2024
Q3 		$1.09M Buy
+29,000
New +$971K ﹤0.01% 1991
2017
Q2 		– Sell
-12,600
Closed -$124K – 4259
2017
Q1 		$124K Buy
+12,600
New +$153K ﹤0.01% 2711

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of Montreal's PTCT Position: Q1 2026 in Review

Bank of Montreal increased its PTC Therapeutics (PTCT) stake by 43% in Q1 2026, buying an estimated $175K and bringing the position to 8,295 shares worth $565K. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

Bank of Montreal first reported a position in PTCT in Q2 2014 and has held it in 32 quarters since. The position peaked at $8.13M in Q3 2024. 351 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Bank of Montreal held 8,295 shares of PTC Therapeutics worth $565K as of Q1 2026.
  • Bank of Montreal bought 2,476 PTC Therapeutics shares in Q1 2026, an estimated $175K.
  • PTC Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2333 holding.
  • Bank of Montreal first reported a position in PTC Therapeutics in Q2 2014 and has held it in 32 quarters since.
  • Bank of Montreal's PTC Therapeutics position peaked at $8.13M in Q3 2024.
  • 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.